BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26746809)

  • 1. Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.
    Hasselmann H; Bellmann-Strobl J; Ricken R; Oberwahrenbrock T; Rose M; Otte C; Adli M; Paul F; Brandt AU; Finke C; Gold SM
    Mult Scler; 2016 Oct; 22(11):1476-1484. PubMed ID: 26746809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial.
    Hunter SF; Agius M; Miller DM; Cutter G; Barbato L; McCague K; Meng X; Agashivala N; Chin P; Hollander E
    J Neurol Sci; 2016 Jun; 365():190-8. PubMed ID: 27206905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms of heart disease or its treatment may increase Beck Depression Inventory Scores in hospitalized post-myocardial infarction patients.
    Delisle VC; Beck AT; Ziegelstein RC; Thombs BD
    J Psychosom Res; 2012 Sep; 73(3):157-62. PubMed ID: 22850253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression.
    Gold SM; Krüger S; Ziegler KJ; Krieger T; Schulz KH; Otte C; Heesen C
    J Neurol Neurosurg Psychiatry; 2011 Jul; 82(7):814-8. PubMed ID: 21296901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing depressive symptoms in multiple sclerosis: is it necessary to omit items from the original Beck Depression Inventory?
    Aikens JE; Reinecke MA; Pliskin NH; Fischer JS; Wiebe JS; McCracken LM; Taylor JL
    J Behav Med; 1999 Apr; 22(2):127-42. PubMed ID: 10374139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in symptoms of depression between females and males with relapsing-remitting multiple sclerosis.
    Mayo CD; Lacey C; Gawryluk JR;
    Mult Scler Relat Disord; 2021 Jun; 51():102884. PubMed ID: 33799287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the presence of multiple sclerosis impact on symptom profile in depressed patients?
    Boeschoten RE; Schaakxs R; Dekker J; Uitdehaag BMJ; Beekman ATF; Smit JH; Penninx BWJH; van Oppen P
    J Psychosom Res; 2017 Dec; 103():70-76. PubMed ID: 29167049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS).
    Greim B; Benecke R; Zettl UK
    J Neurol; 2007 May; 254 Suppl 2():II58-64. PubMed ID: 17503131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
    Wolkorte R; Heersema DJ; Zijdewind I
    Neurorehabil Neural Repair; 2015 Sep; 29(8):796-802. PubMed ID: 25605633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
    Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
    Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural 'connectomic' alterations in the limbic system of multiple sclerosis patients with major depression.
    Nigro S; Passamonti L; Riccelli R; Toschi N; Rocca F; Valentino P; Nisticò R; Fera F; Quattrone A
    Mult Scler; 2015 Jul; 21(8):1003-12. PubMed ID: 25533294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis.
    Rakofsky JJ; Schettler PJ; Kinkead BL; Frank E; Judd LL; Kupfer DJ; Rush AJ; Thase ME; Yonkers KA; Rapaport MH
    J Clin Psychiatry; 2013 Nov; 74(11):1084-91. PubMed ID: 24330894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.
    Montalban X; Comi G; O'Connor P; Gold S; de Vera A; Eckert B; Kappos L
    Mult Scler; 2011 Nov; 17(11):1341-50. PubMed ID: 21727148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.
    Solaro C; Trabucco E; Signori A; Martinelli V; Radaelli M; Centonze D; Rossi S; Grasso MG; Clemenzi A; Bonavita S; D'Ambrosio A; Patti F; D'Amico E; Cruccu G; Truini A
    PLoS One; 2016; 11(9):e0160261. PubMed ID: 27632167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis.
    Kern S; Schultheiss T; Schneider H; Schrempf W; Reichmann H; Ziemssen T
    Psychoneuroendocrinology; 2011 Nov; 36(10):1505-12. PubMed ID: 21621332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients.
    Tsivgoulis G; Triantafyllou N; Papageorgiou C; Evangelopoulos ME; Kararizou E; Sfagos C; Vassilopoulos D
    Acta Neurol Scand; 2007 Jan; 115(1):67-72. PubMed ID: 17156268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.
    Chwastiak L; Ehde DM; Gibbons LE; Sullivan M; Bowen JD; Kraft GH
    Am J Psychiatry; 2002 Nov; 159(11):1862-8. PubMed ID: 12411220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue.
    Kantorová E; Poláček H; Bittšanský M; Baranovičová E; Hnilicová P; Čierny D; Sivák Š; Nosáľ V; Zeleňák K; Kurča E
    Neurol Res; 2017 Apr; 39(4):323-330. PubMed ID: 28191860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?
    Rodgers S; Calabrese P; Ajdacic-Gross V; Steinemann N; Kaufmann M; Salmen A; Manjaly ZM; Kesselring J; Kamm CP; Kuhle J; Chan A; Gobbi C; Zecca C; Müller S; von Wyl V
    J Psychosom Res; 2021 May; 144():110402. PubMed ID: 33631437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis.
    Rossi S; Studer V; Motta C; Polidoro S; Perugini J; Macchiarulo G; Giovannetti AM; Pareja-Gutierrez L; Calò A; Colonna I; Furlan R; Martino G; Centonze D
    Neurology; 2017 Sep; 89(13):1338-1347. PubMed ID: 28842450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.